ArticleInvestigational new drugs2021

A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors.

Geoffrey I Shapiro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.